Stuart Scott Memorial Cancer Research Fund

The V Foundation for Cancer Research established the Stuart Scott Memorial Cancer Research Fund in memory of celebrated ESPN sportscaster Stuart Scott after he passed away on January 4, 2015.

Stuart had always been a dedicated friend to the V Foundation and an inspiration to athletes, fans and fellow broadcasters. When he was diagnosed with cancer, this didn’t change. Stuart was a champion for cancer research and became involved in a clinical trial himself as his fight continued.

Stuart was especially driven to improve outcomes for African Americans and other minorities disproportionately with cancer, and he became a passionate voice on their behalf. According to the Centers for Disease Control and Prevention’s data, there are many examples of cancer disparities among minority populations in the U.S. The Stuart Scott Memorial Cancer Research Fund ensures essential resources are dedicated to these populations.

 

Since inception of the Stuart Scott Fund, the V Foundation has made more than $7.7 million in research grants from combined funds raised through the Sports Humanitarian Awards and additional contributions from the V Foundation. In total, the V Foundation has awarded 22 research grants at 16 cancer centers around the country.

In July 2014, Stuart received the Jimmy V Perseverance Award at the ESPY Awards. During his remarkable speech, he said, “When you die, it does not mean you lose to cancer. You beat cancer by how you live, why you live and in the manner in which you live.” Stuart passed away less than six months later at the age of 49. His extraordinary impact will continue to be felt for years to come.

"When you die, it does not mean that you lose to cancer. You beat cancer by how you live, why you live and in the manner in which you live." - Stuart Scott

Stuart Scott Fund Translational Grant Recipients

Victoria Bae-Jump, M.D., Ph.D.
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Metabolic and Molecular Biomarkers of Metformin Response in Obesity-driven Endometrial Cancer
Funded by the Stuart Scott Memorial Fund

Roisin Connolly, M.D.
Sidney Kimmel Comprehensive Cancer Center/John Hopkins Medicine
Philadelphia, PA
Harnessing the Immune System to Treat Breast Cancer
Funded by the Stuart Scott Memorial Fund

Sanford Markowitz, M.D., Ph.D.
Case Comprehensive Cancer Center
Cleveland, OH
Interpreting the Mutational Signature of African American Colorectal Cancers
Funded by the Stuart Scott Memorial Fund

Matthew Meyerson, M.D., Ph.D.
Dana-Farber Cancer Institute
Boston, MA
The contribution of germline genomic variation to EGFR mutation frequency in non-small cell lung cancers in Latin American populations: implications for cancer risk prediction, screening and intervention.
Funded by the Stuart Scott Memorial Fund

Adam Murphy, M.D.
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, IL
A Prospective Validation of a Prostate Cancer Biomarker in African American Men
Funded by the Stuart Scott Memorial Cancer Research Fund

Jong Park, Ph.D.
Moffitt Cancer Center and Research Institute
Tampa, FL
Genomic predictors of aggressive and lethal prostate cancer in African-American men
Funded by the Stuart Scott Memorial Fund

Ralph Weissleder, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Enhanced holographic diagnostics and profiling of breast cancer using smartphones for point-of-care use
Funded by the Stuart Scott Memorial Fund

 

Stuart Scott Fund V Scholar Grant Recipients

Raymond Blind, Ph.D.
Vanderbilt University School of Medicine
Nashville, TN
Nuclear lipids as hepatocellular carcinoma biomarkers
Funded by the Stuart Scott Memorial Cancer Research Fund

Donita Brady, Ph.D.
University of Pennsylvania School of Medicine
Philadelphia, PA
Targeting autophagy in KRAS-Driven pancreatic cancer via copper reduction
Funded by the Stuart Scott Memorial Cancer Research Fund

Stephanie Correa, Ph.D.
Jonsson Comprehensive Cancer Center
Los Angeles, CA
Hypothalamic targets for mitigating the side effects of adjuvant endocrine therapy
Funded by the Stuart Scott Memorial Cancer Research Fund

Francine Garrett-Bakelman, M.D.
University of Virginia Health System
Charlottesville, VA
Determining of an age-appropriate integrative risk classification in Acute Myeloid Leukemia
Funded by the Stuart Scott Memorial Cancer Research Fund

Gianna Hammer, Ph.D.
Duke Cancer Institute
Durham, NC
Microbiota induced upregulation of PDL√ on intestinal dendritic cells in intestinal tumorigenesis
Funded by the Stuart Scott Memorial Cancer Research Fund

Read More About Dr. Hammer’s Research

Marcela Maus, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Design and pre-clinical evaluation of CAR T cells for myeloma
Funded by the Stuart Scott Memorial Cancer Research Fund

Michelle Mendoza, Ph.D.
Huntsman Cancer Institute, University of Utah
Salt Lake City, UT
Differential Regulation of Tumor Invasion by RSK Family Isoforms
Funded by the Stuart Scott Memorial Cancer Research Fund

Akinyemi Ojesina, M.D., Ph.D.
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, AL
Metatranscriptomic Biomarkers for Predicting Tumor Recurrence
Funded by the Stuart Scott Memorial Fund

Miguel Rivera, M.D.
Massachusetts General Hospital Cancer Center
Charleston, MA
Function of the protein kinase VRK1 in Ewing Sarcoma
Funded by the Stuart Scott Memorial Fund

 

 

Stuart Scott Fund Designated Grant Recipients

Jeffrey Clarke, M.D.
Duke University
Durham, NC
Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Edward Kim, M.D.
Levine Cancer Institute/Carolinas Health Care
Charlotte, NC
Dynamic functional assessment of the host (vs tumor) immune system in patients with non-small cell lung cancer utilizing a novel blood-based immunokinetic platform
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds, and the Richard Jones Fund for lung cancer.

Chad Pecot, M.D.
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Targeting the Immune Microenvironment to Treat Squamous Cancers
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Read More About Dr. Pecot’s Research

Qingy Wei, M.D., Ph.D.
Duke Cancer Institute
Durham, NC
Characterization of functional variants of GWAS-identified CRL-related Gene DCAF4 for racial disparity in lung cancer
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds and the Richard Jones Fund for lung cancer.